Levothyroxine Sodium NDC 50090-7885

Product information

Brand name (proprietary)

Levothyroxine Sodium

Generic name (nonproprietary)

levothyroxine sodium

Active ingredients

Levothyroxine sodium — 125 ug/1

Dosage form

Tablet

Route

Oral

Labeler

A-S Medication Solutions

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 211417

Marketing start

Apr 8, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Thyroxine (Chemical structure)

Identifiers

Product ID 50090-7885_325a5f7a-043f-48ca-86dc-f2295dfda8daSPL ID 325a5f7a-043f-48ca-86dc-f2295dfda8daSPL set ID 2b737395-0238-400b-95ff-890b95c98425RxCUI 966224UNII 9J765S329G

Pharmacologic class

l-Thyroxine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090788500 followed by a unit qualifier and the quantity Copy

Package 50090-7885-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 211417

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 39.